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Pharmacologic Manipulation of the Porcine Ureter: 
Acute Impact of Topical Drugs on Ureteral Diameter 
and Peristaltic Activity
CAROLINE D. AMES, M.D.,1 KYLE J. WELD, M.D.,1 STEPHEN T. DRYER, M.D.,1 GREG HRUBY, M.D.,1
SCOTT D. MINOR, M.D.,1 YAN YAN, M.D.,1 ROBERT S. FIGENSHAU, M.D.,1 SAM BHAYANI, M.D.,1
JAIME LANDMAN, M.D.,2 and RAMAKRISHNA VENKATESH, M.D.1
ABSTRACT
Background and Purpose: Intraluminal application of pharmacologic agents for acute ureteral dilation may
facilitate difficult ureteroscopy. We characterized the in-vivo effects of intraluminal application of verapamil
and theophylline on ureteral peristalsis and diameter in a porcine model.
Materials and Methods: Twenty-four female domestic pigs (35–40 kg) were incorporated into the study. We
deployed a giant magneto resistive (GMR) sensor and electromagnetic (EMG) electrodes laparoscopically onto
the ureteral surface for simultaneous measurement of the mechanical and electrical signals of ureteral peri-
stalsis, respectively. The ureteral-luminal diameter was measured at three levels by digital retrograde pyel-
ography and standardized to a 10-mm laparoscope. The results were calculated as change in peristalsis and
ureteral diameter from baseline during the first hour after drug injection. We tested two smooth-muscle re-
laxants, verapamil (2 mg/kg) and theophylline (70 mg/kg), with saline and dimethylsulfoxide (DMSO; solvent)
as controls. Six pigs were studied for each of the four groups. Hydration, anesthesia, and intra-abdominal
pressure were standardized. The serum concentrations of the drugs were measured to determine systemic ab-
sorption. 
Results: During the first 10 minutes after intraluminal drug injection, theophylline caused a significant de-
crease in ureteral peristalsis (6.75 waves/10 minutes) compared with the control group (1.00/10 minutes; P 
0.02). This trend persisted for the next hour. However, there were no changes from baseline in ureteral width.
Ureteral peristalsis and dilation remained similar after the saline and DMSO injections. Verapamil increased
the diameter of the proximal ureter compared with the controls throughout the hour after drug injection. Fif-
teen minutes after the drug injection, the change in the ureteral diameter with verapamil was 1.38 mm (4.14F),
while the control group showed a change of 0.27 mm (P  0.03). At 1 hour, the width of the proximal ureter
in the verapamil group had increased by 1.72 mm (5.16F), while the control group had changed by 0.55 mm
(P  0.03). There were no statistically significant changes in the widths of the mid or distal ureter. No ureteral
dilation was observed in the other groups.
Conclusions: In the porcine model, intraluminal application of pharmacologic agents produced indepen-
dent effects on ureteral dilation and peristalsis. Theophylline inhibited ureteral peristalsis, and verapamil pro-
duced acute proximal-ureteral dilation. The ability to alter ureteral diameter or peristaltic activity acutely
may facilitate ureteroscopy.
1Department of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri.
2Department of Urology, Columbia University Medical Center, New York, New York.
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INTRODUCTION
URETEROSCOPY has become a mainstay in the urologist’sarmamentarium for ureteral and renal collecting-system
access for both diagnostic and therapeutic purposes. Occasion-
ally, ureteroscopy can be challenging in a nondilated ureter in
which the ureteroscope cannot be passed easily. The inability
to pass the ureteroscope may necessitate either acute dilation
of the ureter or short-term stenting before ureteroscopy.
Application of an intraluminal drug which, on contact with
the ureteral urothelium, causes acute dilation and relaxation of
the ureter without appreciable systemic effects may facilitate
ureteroscopic procedures and increase safety. In addition, re-
laxation of the ureter may facilitate the routine use of larger-
diameter ureteroscopes, which would have greater deflection
and durability and a larger working channel. Acute dilation of
the ureter may also engender spontaneous passage of kidney
stones. Our primary goal was to evaluate pharmacologic agents
to determine if it is feasible to decrease ureteral smooth-mus-
cle tone acutely when such drugs are applied intraluminally
within the ureter.
Studies to evaluate ureteral peristalsis have largely used en-
doluminal methods, employing either a pressure transducer1–4
or an ultrasound probe5 to evaluate ureteral physiology. How-
ever, these endoluminal devices can themselves alter ureteral
peristalsis, and, hence, intraluminal evaluation technologies
cannot be applied to measure ureteral peristalsis and the ureter’s
response to interventions such as stenting accurately.6 Previ-
ously, we reported the design, construction, and implementa-
tion of a novel extraluminal system to evaluate ureteral peri-
stalsis.7 In this study, we utilized this system, which
incorporates electromyographic (EMG) and magnetic sensors,
for extraluminal evaluation of peristalsis in the porcine ureter.
This system is extraluminal and can be deployed using a min-
imally invasive (laparoscopic) technique to ensure minimal al-
teration of the ureteral anatomy and physiology.
MATERIALS AND METHODS
Animals and electromyography measurements
Permission for the study was obtained from the Washington
University Department of Comparative Medicine and the Wash-
ington University Animal Studies Committee. Twenty-four fe-
male domestic pigs (35–40 kg) were divided into four groups
of six animals each. Animals in group 1 received intraluminal
theophylline (70 mg/kg). Animals in group 2 received intralu-
minal verapamil (2 mg/kg). Groups 3 and 4 represented the con-
trol groups, with group 3 receiving 0.9% saline only and group
4 receiving dimethylsulfoxide (DMSO) (solvent) in either 1-
(N  3) or 2-mL (N  3) doses.
After a 16-hour fast but no fluid restriction, the pigs were anes-
thetized using xylazine, 0.45 mg/kg, and intubated and ventilated
using isoflurane anesthesia at a constant concentration of 2%. In-
travenous yohimbine was used to reverse the effects of xylazine
soon after the insertion of trocars. Ketamine and atropine were not
used because of their known significant effects on ureteral peri-
stalsis. The pig was hydrated with intravenous 5% glucose–0.45%
saline at a constant infusion rate of 5 mL/kg of body weight.
The electrical potentials from ureteral peristalsis were mea-
sured by two sets of modified bipolar steel wire EMG elec-
trodes (Fig. 1). The bipolar wire electrodes were mounted on a
23-gauge, three-quarter-inch hypodermic needle to facilitate
laparoscopic deployment onto the serosal surface of the ureter.
The Teflon-coated wires from both electrodes led to two mul-
tipin connectors. The EMG signals from the electrodes were
amplified and displayed on a multichannel oscilloscope (Gould
1604; Gould Equipment, Ilsford, UK).
The mechanical movement of ureteral peristalsis was mea-
sured by the giant magneto resistance (GMR) sensor (Fig. 1).
The magnetic sensor technology consists of a 2  0.5-mm disc-
shaped neodymium magnet that creates a magnetic field and a
GMR sensor (NVE Inc., Eden Prairie, MN), which identifies
any change in the magnetic field produced by movement of an
object placed within the field. The magnet is positioned, and a
small (4  4  0.75-mm) sensor plate is placed on the oppo-
site side of the ureter. The GMR sensor was mounted on a cus-
tom-made aluminum strip for ease of laparoscopic deployment
and for accurate and atraumatic positioning under the ureter.
The sensor uses a Wheatstone bridge circuit, and the signals
from the sensor were amplified and displayed simultaneously
on the same oscilloscope with the EMG signals. This unique
sensor and its method of placement were developed in our lab-
oratory and have been described.7
Operative technique
The pig was placed in a lateral decubitus position, and, us-
ing a three-port laparoscopic technique, the ureter was identi-
fied without any dissection. Pneumoperitoneum pressure was
maintained between 6 and 8 mm Hg to minimize the physio-
logical effects. The peritoneum overlying the upper and mid
ureter was gently reflected medially to expose the surface of
the ureter. 
After exposure of approximately 1 cm of the proximal ureter,
the baseline peristaltic rate was documented by laparoscopic vi-
sual observation for 5 to 10 minutes. Next, the EMG electrodes
and the magnetic sensor were deployed laparoscopically. The
first set of EMG electrodes was placed under the adventitia of
the ureter about 3 cm distal to the ureteropelvic junction, with
the hooks of the electrode wire facing the muscular surface.
Electrode positioning was achieved by inserting the needle
through the adventitia and then retracting it back over the wires,
leaving the tips of the wire electrodes on the ureteral surface.
The second set of EMG electrodes was placed approximately
FIG. 1. Experimental equipment. (A) Neodymium magnetic
disk and (B) GMR sensor. (C) and (D) Bipolar EMG wire elec-
trodes mounted on hyperdermic needle.
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6 to 7 cm distal to the first set. A small (1-cm) window was
created under the ureter for placement of the magnet and the
magnetic sensor between the two sets of EMG electrodes. Care
was taken to preserve the ureteral blood supply to the extent
possible and to cause minimal disturbance of the in-situ ureter.
This arrangement of EMG leads provided good correlation with
endoscopically visible propagative peristaltic waves.
To deploy the GMR sensor, the small magnetic disc was
mounted on an applicator using K-Y jelly to keep it adherent
to the tip. The magnetic surface was coated with a thin layer
of fibrin glue and deployed on the anterior surface of the ureter.
The sensor was positioned under the posterior surface of the
ureter opposite the magnet. As the peristaltic wave propagated
along the ureter, the magnet on the ureteral surface moved in
relation to the sensor, and this movement produced a change in
the magnetic field, which was registered by the GMR sensor.
After the sensors were deployed, the intra-abdominal pres-
sure was reduced to 5 mm Hg to lessen the effect that pneu-
moperitoneum might have on ureteral physiology. Baseline
peristalsis was measured for 1 hour. The GMR and EMG sig-
nals correlated with laparoscopically visible peristalsis. Intra-
venous hydration rate, intra-abdominal pneumoperitoneum
pressure, and anesthetic concentration were also documented
during the observation period. The rate and frequency of peri-
staltic waves were recorded.
A standardized retrograde pyelogram was performed by
passing a 5F open-ended ureteral catheter 2 cm into the distal
ureter under fluoroscopic guidance. The technique for each ret-
rograde evaluation of the ureter was standardized by suspend-
ing a 200-mL bag of saline mixed with 60 mL of Conray
(Mallinckrodt Inc., Hazelwood, MO) 100 cm above the height
of the animal’s bladder. Diluted contrast medium was allowed
to fill the collecting system by gravity for exactly 60 seconds,
at which time, a fluoroscopic plain film was obtained during
the animal’s end-expiratory phase of ventilation. Precise digi-
tal measurements of the ureteral diameter were achieved using
OEC software at the proximal, mid, and distal levels to deter-
mine the diameter during a nonperistaltic phase (Fig. 2). This
method allows accurate measurement, up to 1/100 of a mil-
limeter, with the digital fluoroscopy unit. The proximal-ureteral
measurement was made at the level of the lowest portion of the
ipsilateral lower-pole calix. The mid-ureteral measurement was
acquired at the upper border of the T12 vertebral body, and the
distal ureter was measured at the upper border of the S1 verte-
bral body. A GE-OEC series 9800 digital fluoroscopic unit (GE
OEC Medical Systems, Salt Lake City, UT) was utilized for all
experiments.
Experimental technique
Animals were then randomized into the four drug groups de-
scribed previously. A retrograde pyelogram was obtained after 1
hour of baseline peristalsis monitoring. Next, 10 mL of the ap-
propriate pharmacological agent was injected through the 5F
ureteral catheter over a period of 1 minute. Animals in group 1
received an average of 2.8 g of theophylline, and those in group
2 received 80 mg of verapamil. These dosages were chosen as
they were 10 times the normal systemic dose a human would re-
ceive. Each drug was dissolved in injectable saline, and 1 mL of
DMSO was added as a solvent, for a total volume of 10 mL.
The cystoscope was immediately placed gently against the
ureteral orifice to minimize leakage of the drug out of the ori-
fice; and the catheter, capped by the empty syringe, was held
in the distal ureter over the next 15 minutes to keep the drug
from leaking out. Ureteral peristaltic activity was recorded for
10 minutes immediately after drug injection using the GMR and
EMG configuration described. Immediately after the 10-minute
recording, a Bentson wire was placed through the catheter to
the level of the distal ureter. The catheter was then removed,
allowing drainage of the pharmacologic agent out of the col-
lecting system. Next, the ureteral catheter was replaced into the
distal ureter, and a standardized retrograde pyelogram was per-
formed as previously described. The wire was replaced and the
catheter removed from the ureteral orifice to reduce the effect
the catheter might have on ureteral physiology.
Retrograde studies were procured at baseline and 15, 30, 45,
and 60 minutes after drug injection. Ureteral peristalsis was
measured at 10-minute intervals at baseline (before drug injec-
tion) and then at 0, 15, 30, 45, and 60 minutes postinjection.
The bladder remained decompressed with a Foley catheter
throughout the experiment. Serum drug concentrations were
measured at 15, 30, and 60 minutes after injection of each agent
to assess systemic absorption and effects. After the 60-minute
recordings, the animal was euthanized.
Statistical analysis
Changes from baseline for both peristalsis and ureteral di-
ameter were compared with the values in the control groups us-
ing the least-squares means procedure with Tukey-Kramer ad-
justment for multiple comparisons. Statistics were calculated
using SAS software (V. 9.0; SAS, Cary, NC).
RESULTS
A consistent correlation was found between laparoscopically
observed ureteral peristalsis and the peristalsis detected by the
FIG. 2. Standardized retrograde pyelogram with digital mea-
surements of proximal (P), mid (M), and distal (D) ureter.
EMG electrodes and the magnetic sensor. The EMG action po-
tentials were characterized by multiphasic bipolar spike poten-
tials with rapid onset and return to the baseline. The signals
from the magnetic sensor were characterized as unipolar smooth
deflection and bell shaped. The EMG activity preceded the me-
chanical activity recorded by the magnetic sensor by a few mil-
liseconds. The propagative peristaltic wave seen visually was
correlated with the proximal EMG, the GMR sensor, and the
distal EMG signals on the oscilloscope. There was no change
in the endoscopically visible baseline peristalsis before and af-
ter deployment of the EMG electrodes and the magnetic sen-
sor device, indicating that deployment of the devices themselves
did not affect peristalsis.
Theophylline
Immediately after intraluminal theophylline injection, peri-
staltic activity decreased from a baseline of 6.75/10 minutes to
1.00/10 minutes. In contrast, the saline control group manifested
no change in the rate of peristaltic activity (P  0.02). The trend
to decreased peristalsis continued for the next hour after theo-
phylline injection. This was also statistically significant at 30
minutes, when the number of waves was decreased from
6.75/10 minutes to 0.83/10 minutes. At the 30-minute point, the
saline control group demonstrated no significant change in peri-
staltic rate (P  0.05) (Table 1; Fig. 3). There were no signif-
icant changes in ureteral diameter after theophylline injection
(Table 2). Serum theophylline concentrations averaged 8, 12,
and 20 g/mL at 15, 30, and 60 minutes, respectively. (Stan-
dard human therapeutic values are 10–20 g/mL) There were
no changes in blood pressure or heart rate after theophylline in-
jection. 
Verapamil
Immediately after intraluminal ureteral instillation, vera-
pamil resulted in a significant increase in the number of peri-
staltic waves, from 4.00/10 minutes to 10.83/10 minutes. The
saline control group manifested no change in peristaltic rate
(P  0.03) (Fig. 3). Intraluminal verapamil administration pro-
duced a significantly larger proximal-ureteral diameter at 15
and 60 minutes (Fig. 4). At 15 minutes, the proximal ureter in
the verapamil group had changed from a mean diameter of 7.10
mm to 8.48 mm (increase of 1.38 mm or 4.14F) (P  0.03),
whereas the saline control group did not manifest a significant
change. At 60 minutes, the proximal ureter in the verapamil
group had changed from a diameter of 7.10 mm to 8.82 mm
(increase of 1.72 mm or 5.16F) (P  0.03). There was no
change in the ureteral diameter of the saline control group
(Table 2). There were no significant changes in the mid- or dis-
tal-ureteral diameters.
Serum verapamil concentrations averaged 30, 35, and 43
ng/mL at 15, 30, and 60 minutes and thus were below standard
human therapeutic serum values, which range from 50 to 100
ng/mL. At the 30-minute point, animals in the verapamil group
experienced a significant decrease in systolic blood pressure,
from 98.17 mm Hg to 75.33 mm Hg (P  0.03). There was no
significant change in diastolic blood pressure or heart rate.
DISCUSSION
Several studies have examined the effects of various phar-
macologic agents on ureteral motility. Previous studies have
suggested that both theophylline and calcium-channel blockers
(CCB) such as verapamil may be instrumental in inhibition of
ureteral peristalsis.1,2,8–11
Theophylline has been found to decrease ureteral contractil-
ity when applied systemically in an in-vivo canine model1,2 and
in an in-vitro setting when applied to isolated guinea pig ureters
in a bath of modified Krebs solution.8 To our knowledge, ours
is the first study to quantitate changes in ureteral diameter in
response to pharmacologic manipulation in an in-vivo setting.
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TABLE 1. CHANGE IN URETERAL PERISTALSIS AFTER INJECTION OF PHARMACOLOGIC AGENT
10 min 25 min 40 min 55 min 70 min
Theophylline 5.75a 4.58 5.92 5.58 5.42
Verapamil 6.83a 0.50 0.67 0.67 1.33
Saline 0.70 1.90 2.70 1.70 4.50
DMSO 0.58 4.08 1.25 1.92 0.58
aP  0.05 compared with saline-treated control.
FIG. 3. Ureteral peristalsis after drug injection.
IMPACT OF TOPICAL URETERAL DRUGS 947
Several studies have shown the effect of verapamil and other
CCB of diminishing peristaltic activity when applied to human
and animal ureteral segments in vitro.9–11 Clinically, CCB may
facilitate stone passage through the ureter in both nonsurgi-
cal12,13 and post-SWL14 patients. Stower and colleagues15 ad-
ministered intravenous verapamil in a nonanesthetized canine
model and found decreased ureteral peristalsis in one of five
dogs, but no effect in the remaining four. The current study
showed a temporary increase in ureteral peristalsis after vera-
pamil exposure, with a quick return to baseline. The deviation
in our results from previous findings may be related to inter-
species variability. Alternatively, the most reliable decrease in
peristaltic activity has been demonstrated in the in-vitro setting,
and verapamil may be unreliable in producing ureteral relax-
ation in the intact, in-vivo model. We are uncertain of the rea-
son for the increase in contraction after verapamil administra-
tion in our present study. The study of ureteral smooth-muscle
pharmacology has been fraught with conflicting findings, pos-
sibly because of the many differences in experimental technique
and animal models and the lack of sensitive instrumentation.1
Many techniques for studying pharmacologic action on
ureteral physiology have been described. Investigators have
used in-vivo models with both unanesthetized15 and anesthe-
tized12,13 animals. Also, studies have been done in the unob-
structed as well as obstructed ureter.4 In these studies, the phar-
macologic agents were administered systemically1,2 or applied
topically by dripping the agent into the ureteral lumen through
a catheter.12,13 To date, the in-vitro models described have uti-
lized muscle baths to evaluate ureteral physiology.14,16–18 An
interesting approach to the evaluation of ureteral muscle tone
has been described by Miyatake and associates,19 who described
a model in which the force required to pull a glass bead through
short piece of rabbit ureter was measured before and after ap-
plication of pharmacologic agents. In this model, less force was
required to pull the bead through the ureter after application of
isoproterenol compared with a control ureter.
Our model incorporating the extraluminal EMG and GMR
technologies has some advantages over previously described
techniques for ureteral physiological evaluation. In many con-
temporary in-vivo studies, the authors use an intraluminal pres-
sure transducer to measure ureteral contractions.12,13 However,
the intraluminal transducer itself may result in artefactual re-
sults that affect ureteral motility.
A significant issue in the evaluation of pharmacologic ma-
nipulation of the ureter is the potential for adverse reactions
from systemic absorption. Both Danuser and associates16 and
Hauser and colleagues17 showed that topical phenylephrine ad-
ministration within the ureter in an anesthetized pig model pro-
duces a local effect on the ureter without the systemic side ef-
fects seen when the same drug is given intravenously. These
groups used a 6F dual-lumen catheter placed through the renal
pelvis and into the ureter. One lumen was used for topical drug
administration and the other for recording of ureteral contrac-
tions by pressure transducer.
We used topical administration of the pharmacologic agents
and saw minimal systemic absorption. One group (verapamil)
had a drop in systolic blood pressure 30 minutes after drug ad-
ministration. In this study, we used dosages approximately 10
times the oral (systemic) dose by intraluminal administration
on the basis of our clinical suspicion, as there are no data in
the literature to suggest the appropriate dose. Serum drug con-
centrations were carefully monitored, and although there was
some systemic absorption, the serum values remained within
human therapeutic limits. Certainly, future clinical trials will
have to consider the systemic effects of the pharmacologic
agents applied in regard to patient selection, intraoperative mon-
itoring, and postoperative care.
Our study demonstrates a new method of studying ureteral
physiology using a unique, laparoscopically deployable extra-
luminal method. The GMR sensor is sensitive to small changes
in the magnetic field and allows accurate measurement of dis-
placements of an object in linear, radial, and rotational systems.
TABLE 2. CHANGE IN URETERAL DIAMETER AFTER INJECTION OF PHARMACOLOGIC AGENT
15 min 30 min 45 min 60 min
Prox Mid Distal Prox Mid Distal Prox Mid Distal Prox Mid Distal
Theophylline 0.3 0.18 0.12 0.8 0.53 0.05 0.82 0.14 0.38 0.27 0.02 0.05
Verapamil 1.38a 0.57 0.27 1.48 0.28 0.25 1.17 0.43 0.02 1.72a 0.55 0.05
Saline 0.24 0.34 0.10 0.20 0.43 0.08 0.28 0.50 0.36 0.35 0.13 0.72
DMSO 0.28 0.12 0.07 0.06 0.20 0.27 0.44 0.24 0.13 0.38 0.30 0.30
aP  0.05 compared with saline-treated control.
FIG. 4. Proximal ureteral diameter after drug injection.
This makes the GMR sensor applicable for measuring peristaltic
activity in a tubular structure. The technology is based on the
giant magneto-resistive phenomenon that is being used in the
automobile and aircraft industries for various purposes (e.g.,
throttle positioning, wheel-speed sensing). To our knowledge,
this is the only such application of GMR sensor technology in
a macro biological system and was first described by our lab-
oratory.7
Our technique enabled us for the first time to evaluate the
acute effects of different smooth-muscle relaxants on ureteral
peristalsis. By using this extraluminal approach, we were able
to isolate drug effects, without the artifactual changes asso-
ciated with intraluminal monitoring devices, which are known
to alter ureteral peristaltic activity. Additionally, we de-
scribed the first standardized, digital retrograde urography
system to determine changes in ureteral diameter accurately
as a function of pharmacologic manipulation of in-vivo
ureteral physiology.
The use of minimally invasive techniques to study ureteral
physiology without placing an intraluminal catheter for mea-
surements may help to reveal differences regarding ureteral
smooth-muscle response to pharmacologic agents. 
CONCLUSIONS
The pharmacologic agents manifested independent effects on
ureteral dilation and peristalsis. Intraluminal ureteral theo-
phylline administration caused acute inhibition in ureteral peri-
stalsis with minor increases in serum concentrations and no sig-
nificant change in ureteral diameter. Intraluminal ureteral
verapamil administration yielded significant acute proximal di-
lation. The ability to alter ureteral diameter or peristaltic activ-
ity or both acutely may have important clinical implications for
endoscopic interventions in the upper urinary tract.
ACKNOWLEDGMENT
We thank the Midwest Stone Institute (St. Louis, MO) for
providing a grant to help support this research study.
REFERENCES
1. Boatman DL, Lewin ML, Culp DA, Flocks RH. Pharmacologic
evaluation of ureteral smooth muscle: A technique for monitoring
ureteral peristalsis. Invest Urol 1967;4:509–520.
2. Wein AJ, Gregory JG, Sansone TC, Schoenberg HW. The effects
of aminophylline on ureteral and bladder contractility. Invest Urol
1972;9:290–293.
3. Roshani H, Dabhoiwals NF, Dijkhuis T, Pfaffendorf M, Boon TA,
Lamers WH. Pharmacological modulation of ureteral peristalsis in
a chronically instrumented conscious pig model I: Effect of cholin-
ergic stimulation and inhibition. J Urol 2003;170:264–267.
4. Tomiyama Y, Wanajo, I, Yamazaki Y, Kojima M, Shibata N. Ef-
fects of cholinergic drugs on ureteral function in anesthetized dogs.
J Urol 2004;172:1520–1523.
5. Roshani H, Dabhoiwala NF, Dijhuis T, Kurth KH, Lamers WH.
An in vivo endoluminal ultrasonographic study of peristaltic ac-
tivity in the distal porcine ureter. J Urol 2000;163:602.
6. Dale RL, Constantinou CE, Briggs EM, et al. Dynamics of the up-
per urinary tract: The effect of an indwelling ureteral catheter on
ureteral peristalsis. Invest Urol 1971;8:655. 
7. Venkatesh R, Landman J, Minor SD, et al. Impact of a double-pig-
tail stent on ureteral peristalsis in the porcine model: Initial stud-
ies using a novel implantable magnetic sensor. J Endourol
2005;19:170–176.
8. Bloch R, Decker N, Kostakopoulos A. Effects of theophylline and
isoproterenol on the activity on the isolated guinea pig ureter. Urol
Int 1984;39:308–311.
9. Golenhofen K, Lammel E. Selective suppression of some compo-
nents of spontaneous activity in various types of smooth muscle
by Iproveratril (verapamil). Pflugers Arch Eur J Physiol 1972;
331:233–243.
10. Hertle L, Mawrath H. Calcium channel blockade in smooth mus-
cle of the human upper urinary tract I: Effects on depolarization-
induced activation. J Urol 1984;132:1265–1269.
11. Maggi CA, Meli A. The effect of nifedipine and verapamil on KCl-
induced rhythmic contractions of guinea-pig ureter in vitro. Expe-
rientia 1984l40:681–686.
12. Porpiglia F, Destefanis P, Fiori C, Fontana D. Effectiveness of
nifedipine and deflazacort in the management of distal ureter
stones. Urology 2000;56:579–582.
13. Borghi L, Meschi T, Amato F, Novarini A, Giannini A, Quaran-
telli C, Mineo F. Nifedipine and methylprednisolone in facilitating
ureteral stone passage: A randomized, double-blind, placebo-con-
trolled study. J Urol 1994;152:1095–1098.
14. Porpiglia F, Destefanis P, Fiori C, Scarpa RM, Fontana D. Role of
adjunctive medical therapy with nifedipine and deflazacort after
extracorporeal shock wave lithotripsy of ureteral stones. Urology
2002;59:835–838.
15. Stower MJ, Clark AG, Wright JW, Hardcastle JD. The effect of
various drugs on canine ureteric peristalsis. Urol Res 1986;14:
41–44.
16. Danuser H, Weiss, R, Abel D, Walter B, Scholtysik G, Mettler D,
Studer UE. Systemic and topical drug administration in the pig
ureter: Effect of phyosphodiesterase inhibitors a1,  and 2-ad-
renergic receptor agonists and antagonists on the frequency and
amplitude of ureteral contractions. J Urol 2001;166:714–720.
17. Hauser DS, Mevissen M, Weiss R, Portier CJ, Scholytsik G, Studer
UE, Danuser H. Effects of ketanserin and DOI on spontaneous and
5-HT-evoked peristalsis of the pig ureter in vivo. Br J Pharmacol
2002;135:1026–1032.
18. Cole RS, Fry CH, Shuttleworth KED. The action of the prosta-
glandins on isolated human ureteric smooth muscle. Br J Urol
1988;61:19–26.
19. Miyatake R, Tomiyama Y, Murakami M, Park Y, Kurita T. Effects
of isoproterenol and butyscopolamine on the friction between an
artificial stone and the intraureteral wall in anesthetized rabbits. J
Urol 2001;166:1083–1087.




St. Louis, MO 63110
E-mail: rvenkateshat@aol.com
ABBREVIATIONS USED
CCB  calcium channel blockers; EMG  electromyogra-
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